| HOME >> BIOLOGY >> TECHNOLOGY |
Interest Expense, net 956 1.7% 1,069 1.9%
Other Expense, net 485 0.8% 548 1.0%
Income Before Income Taxes 3,101 5.5% 1,856 3.4%
Provision for Income Taxes 304 0.6% 4,592 8.4%
Income/(Loss) from Continuing
Operations $2,797 4.9% $(2,736) -5.0%
Income from Discontinued
Operations, Net of Tax - 0.0% 4,229 7.7%
Net Income $2,797 4.9% $1,493 2.7%
Basic Earnings/(Loss) per Share
Income/(Loss) from Continuing
Operations $0.10 $(0.09)
Income from Discontinued
Operations, Net of Tax $- $0.14
Net Income $0.10 $0.05
Diluted Earnings/(Loss) per Share
Income/(Loss) from Continuing
Operations $0.10 $(0.09)
Income from Discontinued
Operations, Net of Tax $- $0.14
Net Income $0.10 $0.05
Weighted Average Shares Outstanding
Basic 29,163 28,934
Diluted 29,178 28,934
CAMBREX CORPORATION
Statement of Profit and Loss
For the Nine Months Ended September 30, 2008 and 2007
(in thousands)
2008 2007
% of % of
Amount Sales Amount Sales
Gross Sales $184,440 100.0% $182,820 100.0%
Allo
'/>"/>
| SOURCE Cambrex Corporation Copyright©2008 PR Newswire. All rights reserved |